Virus-like Particles
Showing 1 - 25 of >10,000
Glioblastoma Trial (MRI scan using USPIO particles)
Not yet recruiting
- Glioblastoma
- MRI scan using USPIO particles
- (no location specified)
Dec 15, 2022
Virus Diseases, RNA Virus Infections, Respiratory Tract Infections Trial in Canada (Quadrivalent VLP Influenza Vaccine)
Completed
- Virus Diseases
- +3 more
- Quadrivalent VLP Influenza Vaccine
-
Halifax, Nova Scotia, Canada
- +9 more
Jun 8, 2020
Healthy Trial in Hollywood, Atlanta, Omaha (IVX-121, IVX-241, Placebo)
Recruiting
- Healthy
- IVX-121
- +3 more
-
Hollywood, Florida
- +2 more
Dec 22, 2022
Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases Trial in Worldwide (Quadrivalent VLP Vaccine, Placebo)
Completed
- Virus Diseases
- +3 more
- Quadrivalent VLP Vaccine
- Placebo
-
Mobile, Alabama
- +72 more
Oct 29, 2020
Chikungunya Virus Infection Trial (PXVX0317 vaccine booster, Placebo booster)
Not yet recruiting
- Chikungunya Virus Infection
- PXVX0317 vaccine booster
- Placebo booster
- (no location specified)
Aug 18, 2023
Chikungunya Virus Trial in Lenexa (CHIKV VLP, adjuvanted)
Completed
- Chikungunya Virus
- CHIKV VLP, adjuvanted
-
Lenexa, KansasJohnson County ClinTrials
Jul 18, 2022
Influenza, Human Trial (FLU Q-PAN H5N8 Formulation 1, AS03B, AS03A)
Not yet recruiting
- Influenza, Human
- FLU Q-PAN H5N8 Formulation 1
- +3 more
- (no location specified)
Jul 27, 2023
Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases Trial in Canada, United States (15 µg/strain of Quadrivalent
Completed
- Virus Diseases
- +3 more
- 15 µg/strain of Quadrivalent VLP Vaccine
- +2 more
-
Hollywood, Florida
- +8 more
Jun 8, 2020
Acute Bronchiolitis Due to Respiratory Syncytial Virus Trial in Ghent (V-306 candidate vaccine)
Completed
- Acute Bronchiolitis Due to Respiratory Syncytial Virus
- V-306 candidate vaccine
-
Ghent, BelgiumCentre for Vaccinology (CEVAC)
Mar 4, 2022
Influenza-like Illness (Including COVID-19)
Suspended
- Influenza
- +7 more
- Respiratory infections
-
London, United KingdomImperial College London
Jul 27, 2022
Covid19 Trial in Ankara (SARS-CoV-2 VLP Vaccine, Placebo)
Completed
- Covid19
- SARS-CoV-2 VLP Vaccine
- Placebo
-
Ankara, TurkeyDr. Abdurahman Yurtaslan Ankara Oncology Training and Research H
May 24, 2022
Nosocomial Influenza Surveillance of 2022 - 2027 Seasonal Period
Not yet recruiting
- Infection Viral
- Influenza-like illness group
- (no location specified)
Feb 3, 2023
Healthy Trial in United States (IVX-A12, Placebo)
Recruiting
- Healthy
- IVX-A12
- Placebo
-
Tempe, Arizona
- +9 more
Jun 5, 2023
Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III), Human Papillomavirus (HPV) Infections, High-risk HPV Trial
Recruiting
- Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III)
- +3 more
- Nonavalent HPV vaccine (9vHPV/Gardasil-9™).
-
L'Hospitalet De Llobregat, Catalunya, SpainGynaecology Unit, Bellvitge University Hospital (HUB)
Jan 24, 2023
Covid19 Trial in Ankara, Istanbul, Kocaeli (SARS-CoV-2 VLP Vaccine-Wuhan, SARS-CoV-2 VLP Vaccine-Alpha (British) variant,
Completed
- Covid19
- SARS-CoV-2 VLP Vaccine-Wuhan
- +2 more
-
Ankara, Turkey
- +2 more
May 24, 2022
Chikungunya Trial in Fort Deterick, Silver Spring (Chikungunya)
Completed
- Chikungunya
- Chikungunya
-
Fort Deterick, Maryland
- +1 more
Jan 4, 2022
Healthy Volunteers, Norovirus Trial in Belgium, United States (NoV Vaccine)
Completed
- Healthy Volunteers
- Norovirus
- NoV Vaccine
-
Birmingham, Alabama
- +10 more
Nov 7, 2022
Malaria, Plasmodium Falciparum Trial (Matrix-M with RH5.2 VLP and/or R21)
Not yet recruiting
- Malaria, Plasmodium Falciparum
- Matrix-M with RH5.2 VLP and/or R21
- (no location specified)
Oct 21, 2022
Venezuelan Equine Encephalitis, Western Equine Encephalitis, Eastern Equine Encephalitis Trial in Decatur (VRC-WEVVLP073-00-VP,
Completed
- Venezuelan Equine Encephalitis
- +3 more
- VRC-WEVVLP073-00-VP
- VRC-GENMIX083-AL-VP
-
Decatur, GeorgiaThe Hope Clinic of the Emory Vaccine Center
Mar 23, 2021
Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases Trial in Pierrefonds, Québec (Non-adjuvanted low dose of
Completed
- Virus Diseases
- +3 more
- Non-adjuvanted low dose of quadrivalent VLP vaccine
- +5 more
-
Pierrefonds, Quebec, Canada
- +2 more
Oct 31, 2019
HIV Trial in Rochester (HIV p17/p24:Ty-VLP, Aluminum hydroxide)
Completed
- HIV Infections
- HIV p17/p24:Ty-VLP
- Aluminum hydroxide
-
Rochester, New YorkUniv. of Rochester AVEG
Oct 28, 2021
A Multicenter, Randomized, Placebo-Controlled, Double-Blind
Withdrawn
- HIV Infections
- (no location specified)
Oct 27, 2021
Condylomata Acuminata Trial (low dosage HPV Vaccine(1:1), low dosage HPV Vaccine(1:2), high dosage HPV Vaccine(1:1))
Active, not recruiting
- Condylomata Acuminata
- low dosage HPV Vaccine(1:1)
- +3 more
- (no location specified)
Feb 10, 2022
Healthy Volunteers Trial in Great Lakes (NoV Placebo-matching Saline, NoV GI.1/GII.4 Bivalent VLP Vaccine)
Completed
- Healthy Volunteers
- NoV Placebo-matching Saline
- NoV GI.1/GII.4 Bivalent VLP Vaccine
-
Great Lakes, IllinoisGreat Lakes Naval Station
May 14, 2021
COVID-19, Coronavirus Infections Trial in Canada (VBI-2901a)
Recruiting
- COVID-19
- Coronavirus Infections
- VBI-2901a
-
Halifax, Nova Scotia, Canada
- +6 more
Nov 16, 2022